XML 20 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION
9 Months Ended
Sep. 30, 2018
SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION  
SUPPLEMENTAL CONSOLIDATED BALANCE SHEET INFORMATION

4. SUPPLEMENTAL CONSOLIDATED FINANCIAL STATEMENT INFORMATION

 

Except for the items mentioned below, no other balance sheet opening balances were materially impacted at January 1, 2017 for the adoption of Topic 606.

 

Deferred Costs (in thousands)

 

The opening balance of deferred cost was $2,991 and $3,668 at January 1, 2018 and 2017, respectively. The Company’s prepaid expenses and other current assets at September 30, 2018 and 2017 included deferred costs incurred to fulfill contracts with customers of $3,157 and $1,625, respectively.

 

Deferred costs at September 30, 2018 compared to January 1, 2018 remained fairly consistent. Deferred cost at September 30, 2017 compared to January 1, 2017 decreased primarily as a result of the completion of several projects during that nine month period that had significant deferred fulfillment costs at January 1, 2017.

 

The amount of total deferred costs amortized for the third quarter and first nine months of 2018 was $14,757 and $29,004, respectively. The amount of total deferred cost amortized for the third quarter and first nine months of 2017 was $12,485 and $35,773, respectively. There were no material impairment losses incurred during these periods.

 

Deferred Revenue (in thousands)

 

The opening balance of deferred revenue was $6,314 and $5,385 at January 1, 2018 and 2017, respectively. The Company’s deferred revenue at September 30, 2018 and 2017 was $2,779 and $4,587, respectively.

 

Deferred revenue at September 30, 2018 compared to January 1, 2018 decreased primarily as a result of completing projects for clients with large prepayments for third party reimbursables. Deferred revenue at September 30, 2017 compared to January 1, 2017 decreased primarily as a result of the completion of projects that had deferred revenue at January 1, 2017.

   

Revenue recognized for the third quarter and first nine months of 2018 that was included in the contract liability balance at the beginning of 2018 was $634 and $5,945, respectively. Revenue recognized for the third quarter and first nine months of 2017 that was included in the contract liability balance at the beginning of 2017 was $96 and $4,806, respectively.

 

Adjustments to Condensed Consolidated Financial Statements

 

The following tables reflect the adjustments applied to our condensed consolidated financial statements related to both the adoption of Topic 606 and the 5% stock dividend discussed in Note 2 – Summary of Significant Accounting Policies’ Basis of Presentation.

 

Select line items from the Company’s Condensed Consolidated Balance Sheets which reflect the adoption of the new standard and 5% stock dividend are as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

 

As Previously Reported

 

Topic 606 Adjustments

 

Stock Dividend Adjustments

 

As Adjusted

Current assets:

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

$

33,138

 

$

18

 

 

 

 

$

33,156

Prepaid expenses and other current assets

$

4,677

 

$

2,663

 

 

 

 

$

7,340

Current liabilities:

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue

$

3,699

 

$

2,615

 

 

 

 

$

6,314

Stockholders' equity:

 

 

 

 

 

 

 

 

 

 

 

Common Stock

$

218

 

 

 

 

$

11

 

$

229

Additional paid-in capital

$

143,835

 

 

 

 

$

8,046

 

$

151,881

Retained deficit

$

(2,021)

 

$

66

 

$

(8,057)

 

$

(10,012)

 

Select line items from the Company’s Condensed Consolidated Statements of Operations and Comprehensive Loss which reflect the adoption of the new standard and the 5% stock dividend are as follows (in thousands except share and per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2017

 

As Previously Reported

 

Topic 606 Adjustments

 

Stock Dividend Adjustments

 

As Adjusted

Operating revenues

$

45,627

 

$

(519)

 

 

 

 

$

45,108

Operating costs:

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

$

36,594

 

$

(356)

 

 

 

 

$

36,238

Loss from operations

$

(4,136)

 

$

(163)

 

 

 

 

$

(4,299)

Net loss

$

(2,759)

 

$

(163)

 

 

 

 

$

(2,922)

Basic and diluted loss per share of common stock

$

(0.13)

 

$

 

$

 

$

(0.13)

Weighted average equivalent common shares

 

 

 

 

 

 

 

 

 

 

 

outstanding and outstanding - assuming dilution

 

21,701,662

 

 

 

 

 

1,085,083

 

 

22,786,745

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2017

 

As Previously Reported

 

Topic 606 Adjustments

 

Stock Dividend Adjustments

 

As Adjusted

Operating revenues

$

118,023

 

$

1,091

 

 

 

 

$

119,114

Operating costs:

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

$

107,639

 

$

1,371

 

 

 

 

$

109,010

Loss from operations

$

(31,662)

 

$

(280)

 

 

 

 

$

(31,942)

Net loss

$

(26,722)

 

$

(280)

 

 

 

 

$

(27,002)

Basic and diluted loss per share of common stock

$

(1.23)

 

$

 

$

0.04

 

$

(1.19)

Weighted average equivalent common shares

 

 

 

 

 

 

 

 

 

 

 

outstanding and outstanding - assuming dilution

 

21,681,474

 

 

 

 

 

1,084,074

 

 

22,765,548

 

Select line items from the Company’s Condensed Consolidated Statements of Cash Flows which reflect the adoption of the new standard are as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2017

 

As Previously Reported

 

Topic 606 Adjustments

 

 

As Adjusted

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

$

(26,722)

 

$

(280)

 

$

(27,002)

Change in current assets and liabilities:

 

 

 

 

 

 

 

 

Increase in accounts receivable

$

(9,568)

 

$

197

 

$

(9,371)

(Increase) decrease in prepaid expenses and other current assets

$

(1,135)

 

$

1,301

 

$

166

Increase in accounts payable

$

2,197

 

$

70

 

$

2,267

Increase (decrease) in deferred revenue

$

489

 

$

(1,288)

 

$

(799)

Net cash used in operating activities

$

(3,309)

 

$

 

$

(3,309)